Protalix BioTherapeutics Inc $3.37

down -0.12


23/7/2014 04:00 PM  |  AMEX : PLX  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get PLX Trend Analysis - it has underperformed the S&P 500 by 56%

Partner Headlines

  1. Stocks Hitting 52-Week Lows

    Benzinga
  2. Facebook Leads 3 High-Volume Young Gun Stock Leaders

    IBD
  3. Protalix Biotherapeutics Reports New Data on ELELYSO, Oral GCD Will Be ...

    Benzinga
  4. Protalix Offers Update on Health Canada Evaluation, Says Manufacturing ...

    Benzinga
  5. Protalix Reports Oral GCD Well Toleratead, Active Enzyme Detected in Blood

    Benzinga
  6. Protalix BioTherapeutics Announces Proposed $60M Offering of Convertible ...

    Benzinga
  7. Protalix Says New Clinical Data on ELELYSO Will Be Presented at WORLD Symposium

    Benzinga
  8. Benzinga's M&A Chatter for Tuesday February 5, 2013

    Benzinga
  9. Mid-Afternoon Market Update: Markets Edge Toward Record Highs, Arch Coal ...

    Benzinga
  10. Mid-Day Market Update: Markets Rally Further, Clean Harbors Drops on CFO ...

    Benzinga
  11. Protalix Says Reviewing Partnering, Other Alternatives

    Benzinga
  12. Protalix BioTherapeutics Signs Clinical Development Agreement With Pfizer ...

    Benzinga
  13. Protalix BioTherapeutics Inc Reports Operating Results (10-Q)

    GuruFocus
  14. Protalix BioTherapeutics Receives FDA IND Clearance to Initiate a Phase ...

    Benzinga
  15. Protalix BioTherapeutics Inc Reports Operating Results (10-Q)

    GuruFocus
  16. Benzinga's Downgrade Summary for June 25, 2012

    Benzinga
  17. Ryder System, Associated Estates Realty Corporation Among Stocks Down on ...

    FoxBusiness
  18. Ryder System, Protalix BioTherapeutics Gapping Down Friday

    FoxBusiness
  19. Protalix BioTherapeutics (PLX) Gains 18% After FDA Approval

    MarketIntelligenceCenter
  20. Protalix BioTherapeutics Inc Reports Operating Results (10-K)

    GuruFocus
  21. Notable Call Options Activity in Protalix BioTherapeutics

    Benzinga
  22. Protalix BioTherapeutics Announces the Pricing of Public Offering of Common ...

    Benzinga
  23. Protalix BioTherapeutics Announces Proposed Public Offering of Common Stock; ...

    Benzinga
  24. FDA Delays Protalix's Drug Decision; Investors Feel Sick

    Benzinga
Trading Center